CLINICAL QUESTION: Do statins reduce rates of cardiovascular events when used for primary prevention? BOTTOM LINE: When used for primary prevention, statins are associated with lower rates of all-cause mortality, major vascular events, and revascularizations compared with placebo. Statin therapy is not associated with increased rates of life-threatening adverse effects such as cancer.